Page 23 - Vaccine

Clinically tried and tested: Bharat Biotech boss Ella wins Covaxin fight

Covaxin was India's first indigenously developed vaccine to be approved, controversially under "clinical trial mode" in the first week of January

Approve more vaccines

There are several reasons why we are not yet, as Union Health Minister Harsh Vardhan claimed recently, in the "the endgame" of the pandemic in this country

US export curbs can limit Covid shot production, availability: Poonawalla

The production of coronavirus vaccines and scaling up global availability could be seriously limited due to ban on exports of critical raw materials by the US, according to SII CEO Adar Poonawalla

PM Modi kicks off third phase of vaccination, takes first jab of Covaxin

In the age group of 45-60 years of age around 18,850 got the first dose and more than 128,000 beneficiaries over 60 years of age got the shot on Monday

Covid-19 vaccination: Centres witness enthusiastic response on Day 1

Even as the upgraded Co-WIN was launched, technical glitches continued and many places got off to a late start.

Healing a weak regulator

Weaknesses in India's drug regulatory regime and the constraints and questionable decisions of the drug regulator could mar the country's reputation in global markets

J&J's 1-dose shot cleared, giving US 3rd Covid-19 vaccine

The US is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two. Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a virus that already has killed more than 510,000 people in the US and is mutating in increasingly worrisome ways. The FDA said J&J's vaccine offers strong protection against what matters most: serious illness, hospitalizations and death. One dose was 85% protective against the most severe COVID-19 illness, in a massive study that spanned three continents protection that remained strong even in countries such as South Africa, where the variants of most concern are spreading. The more vaccines that have high efficacy that we can get into play, the better, Dr. Anthony Fauci, the top US infectious disease expert, said ahead of the FDA's ruling. Shipments of a few million doses to be divided ...

Strides Pharma to spin off biopharma biz, start vaccines with global player

Entity Stelis Biopharma to require up to $100-mn additional funds in 3 years

Glitches in Co-WIN are minor, new system to work like RAC: R S Sharma

R S Sharma, who chairs the empowered committee on technology for Covid vaccine, spoke to Nivedita Mookerji on what went wrong with Co-Win during the first few days, the scale-up exercise, and more

The campaign for Covid-19 vaccine requires a 360-degree approach

Some lessons can be drawn from the two-decade-long pulse polio mass immunisation campaign that was memorably captured by an iconic phrase: "Do boond zindagi ki (Two drops of life)."

Adverse effect of Covid-19 vaccine: What the law says, or doesn't

Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with the kind of approvals given, say legal experts

Vardhan launches indigenously developed pneumococcal vaccine 'Pneumosil'

Pneumosil was found to be safe and effective in the prevention of pneumonia and based on which Pneumosil has been licensed by the Drugs Controller General of India in July 2020

India's first fully indigenous pneumococcal vaccine launched

Serum Institute of India announced the launch of India's first indigenously developed pneumococcal vaccine -- Pneumosil

Boston doctor reports allergic reaction after getting Moderna's vaccine

The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine

Decoded: What emergency use authorisation of Covid vaccine means for us

After the Indian arm of US pharmaceutical giant Pfizer, the Serum Institute of India has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation

Women take lead in Covid-19 vaccine development: Here's what it teaches us

The core work behind the mRNA approach comes from Katalin Karikó, a Hungarian-born emigre who came to the U.S. to work on RNA-related issues

India Coronavirus Dispatch: Vaccine volunteers say the risk was worth it

Is the Pfizer vaccine the right fit for India, celebrity ambassadors to drum up interest in vaccinations, how herd immunity works-news relevant to India's fight against Covid-19

Wockhardt in talks with global vaccine firms for contract manufacturing

UK site would fill-finish 100 mn doses of AstraZeneca vaccine, has 350 mn dose capacity; Aurangabad can make has 1 bn doses, vaccine raw materials

Covishield's approval process hinges on adverse event investigation

SII has in response stated that the allegations made in the legal notice are 'malicious and misconceived', and that it will seek damages in excess of Rs 100 crore.

Indian Immunologicals to set up new vaccine plant, raise capacity by 35%

Commissions a Rs 75 cr viral antigen unit, inaugurates new filling plant